
<TYPE>EX-10.11
<SEQUENCE>14
<FILENAME>d67753dex1011.htm
<DESCRIPTION>EX-10.11
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.11</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">
  
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.11 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT WERE OMITTED AND REPLACED WITH &#147;[***]&#148;. A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY
WITH THE SECRETARY OF THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO AN APPLICATION REQUESTING CONFIDENTIAL TREATMENT PURSUANT TO RULE 406 PROMULGATED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ADDENDUM TO LICENSE AGREEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Addendum to License Agreement (this Addendum&#148;) is made and entered into as of February&nbsp;2, 2016 (the &#147;Addendum Date&#148;),
and amends that certain License Agreement dated as of July&nbsp;16, 2014, as amended or supplemented through the Amendment Date (the &#147;License Agreement&#148;), by and between Caribou Biosciences, Inc. (&#147;Caribou&#148;) and Intellia
Therapeutics, Inc. (as successor in interest and assignee of Intellia, LLC, and herein thereafter referred to as &#147;Intellia&#148;). Each of Caribou and Intellia may be referred to herein as a &#147;Party&#148; or together as the
&#147;Parties.&#148; Capitalized terms not otherwise defined herein shall have the meanings ascribed to such terms in the License Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>WHEREAS</B>, Caribou and Pioneer Hi-Bred International, Inc. (&#147;Pioneer&#148;) have entered into that certain Amended and Restated
Collaboration and License Agreement, dated as of July&nbsp;13, 2015, as may be amended or restated (the &#147;Pioneer Agreement&#148;), pursuant to which Caribou has been granted certain rights and licenses under proprietary and intellectual
property rights of Pioneer and its affiliates, including E.I. du Pont de Nemours&nbsp;&amp; Company (&#147;DuPont&#148;):<B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>WHEREAS</B>, the fields in which Caribou has been granted certain rights and licenses under the Pioneer Agreement include [***] the
Intellia Field;<B> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>WHEREAS</B>, pursuant to Caribou&#146;s obligations and Intellia&#146;s rights under Section&nbsp;2.7(a) of the
License Agreement, Caribou notified Intellia [***] of its execution of the Pioneer Agreement as a New In-License (as defined in the License Agreement), and Intellia notified Caribou [***] of its election to take the benefit of such New In-License;
and<B> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>WHEREAS</B>, the Parties wish to enter into this Addendum to memorialize the terms and conditions applicable to such New
In-License.<B> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>NOW</B>, <B>THEREFORE</B>, in consideration of the mutual covenants contained herein and other good and valuable
consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties hereto agree as follows to be effective as of the Addendum Date:<B> </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> 
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%"> 
<TR> 
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.</TD> 
<TD ALIGN="left" VALIGN="top">This Addendum is an Included In-License Addendum as set forth in Section&nbsp;2.7(a) of the License Agreement, and, as of the Addendum Date, the Pioneer Agreement is a Caribou Included In-License, as defined in
Section&nbsp;2.7(a) and a Caribou In-License as defined in Section&nbsp;1.7 of the License Agreement. Asterisked terms used in this Addendum shall have the meanings set forth in the Pioneer Agreement. </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> 
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%"> 
<TR> 
<TD WIDTH="4%" VALIGN="top" ALIGN="left">2.</TD> 
<TD ALIGN="left" VALIGN="top">From the Addendum Date, DuPont Pioneer Background IP*, DuPont Pioneer Background Confidential Information,* Pioneer&#146;s and its Affiliates&#148; rights in Program Results,* and Caribou&#146;s and its Affiliates&#146;
rights in Program Results* are added to Caribou IP and included in the scope of the licenses granted to Intellia in the Intellia Field under Section&nbsp;2.1 of the License Agreement for the duration of the License Term,* and, after expiration of
the Pioneer Agreement, such licenses will become non-exclusive, perpetual, irrevocable, fully paid-up and royalty-free. </TD></TR></TABLE> 
 
<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
  
 
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%"> 
<TR> 
<TD WIDTH="4%" VALIGN="top" ALIGN="left">3.</TD> 
<TD ALIGN="left" VALIGN="top">Milestone Payments. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> 
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%"> 
<TR> 
<TD WIDTH="4%">&nbsp;</TD> 
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(a)</TD> 
<TD ALIGN="left" VALIGN="top">For so long as Caribou&#146;s license in the [***] is exclusive and such payments required under the Pioneer Agreement, Intellia will pay the following milestone payments to Caribou, as a pass-through to Pioneer, for
[***] of Intellia, its Affiliate or its Sublicensee in the Intellia Field. Each milestone payment shall be payable [***] upon the [***] achievement of the corresponding milestone event, except as expressly set forth in Section&nbsp;3(vii).
</TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">[***] </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> 
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%"> 
<TR> 
<TD WIDTH="4%">&nbsp;</TD> 
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(b)</TD> 
<TD ALIGN="left" VALIGN="top">Intellia acknowledges that Caribou owes the above milestone payments to Pioneer within [***] of the occurrence of the corresponding milestone events, and, if due by Intellia, agrees to pay the above milestone payments
to Caribou within [***] of the occurrence of the corresponding milestone events by Intellia, its Affiliate or Sublicensee. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> 
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%"> 
<TR> 
<TD WIDTH="4%">&nbsp;</TD> 
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(c)</TD> 
<TD ALIGN="left" VALIGN="top">Intellia will provide Caribou written notice within [***] after achievement of a milestone event set forth in Section&nbsp;4(a). </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> 
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%"> 
<TR> 
<TD WIDTH="4%" VALIGN="top" ALIGN="left">4.</TD> 
<TD ALIGN="left" VALIGN="top">Intellia&#146;s rights under Sections 4.1(h)(i), 4.2(g)(i) and 4.3 of the License Agreement will extend to all Patents within [***] as provided by the Pioneer Agreement. </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> 
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%"> 
<TR> 
<TD WIDTH="4%" VALIGN="top" ALIGN="left">5.</TD> 
<TD ALIGN="left" VALIGN="top">Intellia&#146;s obligation to maintain the DuPont Pioneer Background Confidential Information in confidence will cease [***]. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> 
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%"> 
<TR> 
<TD WIDTH="4%" VALIGN="top" ALIGN="left">6.</TD> 
<TD ALIGN="left" VALIGN="top">To the extent not expressly supplemented by this Addendum, the License Agreement remains in full force and effect. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> 
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%"> 
<TR> 
<TD WIDTH="4%" VALIGN="top" ALIGN="left">7.</TD> 
<TD ALIGN="left" VALIGN="top">This Addendum may be executed in one or more counterparts, each of which together will be deemed an original, and all of which together will be deemed to be one and the same instrument. Facsimile or PDF execution and
delivery of this Addendum by either Part) will constitute a legal, valid and binding execution and delivery of this Addendum by such Party. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>IN WITNESS WHEREOF</B>, the Parties hereto have duly executed and delivered this Addendum to the License Agreement as of the Addendum
Date<B> </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> 
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">

 
<TR> 
<TD WIDTH="4%"></TD> 
<TD VALIGN="bottom" WIDTH="1%"></TD> 
<TD WIDTH="42%"></TD> 
<TD VALIGN="bottom" WIDTH="1%"></TD> 
<TD WIDTH="4%"></TD> 
<TD VALIGN="bottom" WIDTH="1%"></TD> 
<TD WIDTH="4%"></TD> 
<TD VALIGN="bottom" WIDTH="1%"></TD> 
<TD WIDTH="42%"></TD></TR>

 
<TR STYLE="font-family:Times New Roman; font-size:10pt"> 
<TD VALIGN="top" COLSPAN="3"><B>CARIBOU BIOSCIENCES, INC.</B></TD> 
<TD VALIGN="bottom">&nbsp;</TD> 
<TD VALIGN="top"></TD> 
<TD VALIGN="bottom">&nbsp;</TD> 
<TD VALIGN="top" COLSPAN="3"><B>INTELLIA THERAPEUTICS, INC.</B></TD></TR> 
<TR STYLE="font-size:1pt"> 
<TD HEIGHT="16"></TD> 
<TD HEIGHT="16" COLSPAN="2"></TD> 
<TD HEIGHT="16" COLSPAN="2"></TD> 
<TD HEIGHT="16" COLSPAN="2"></TD> 
<TD HEIGHT="16" COLSPAN="2"></TD></TR> 
<TR STYLE="font-family:Times New Roman; font-size:10pt"> 
<TD VALIGN="top">By:</TD> 
<TD VALIGN="bottom">&nbsp;</TD> 
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Rachel E. Haurwitz</P></TD> 
<TD VALIGN="bottom">&nbsp;</TD> 
<TD VALIGN="top"></TD> 
<TD VALIGN="bottom">&nbsp;</TD> 
<TD VALIGN="top">By:</TD> 
<TD VALIGN="bottom">&nbsp;</TD> 
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Nessan Bermingham</P></TD></TR> 
<TR STYLE="font-size:1pt"> 
<TD HEIGHT="8"></TD> 
<TD HEIGHT="8" COLSPAN="2"></TD> 
<TD HEIGHT="8" COLSPAN="2"></TD> 
<TD HEIGHT="8" COLSPAN="2"></TD> 
<TD HEIGHT="8" COLSPAN="2"></TD></TR> 
<TR STYLE="font-family:Times New Roman; font-size:10pt"> 
<TD VALIGN="top">Name:</TD> 
<TD VALIGN="bottom">&nbsp;</TD> 
<TD VALIGN="top">Rachel E. Haurwitz, Ph.D.</TD> 
<TD VALIGN="bottom">&nbsp;</TD> 
<TD VALIGN="top"></TD> 
<TD VALIGN="bottom">&nbsp;</TD> 
<TD VALIGN="top">Name:</TD> 
<TD VALIGN="bottom">&nbsp;</TD> 
<TD VALIGN="top">Nessan Bermingham, Ph.D.</TD></TR> 
<TR STYLE="font-size:1pt"> 
<TD HEIGHT="8"></TD> 
<TD HEIGHT="8" COLSPAN="2"></TD> 
<TD HEIGHT="8" COLSPAN="2"></TD> 
<TD HEIGHT="8" COLSPAN="2"></TD> 
<TD HEIGHT="8" COLSPAN="2"></TD></TR> 
<TR STYLE="font-family:Times New Roman; font-size:10pt"> 
<TD VALIGN="top">Title:</TD> 
<TD VALIGN="bottom">&nbsp;</TD> 
<TD VALIGN="top">President&nbsp;&amp; CEO</TD> 
<TD VALIGN="bottom">&nbsp;</TD> 
<TD VALIGN="top"></TD> 
<TD VALIGN="bottom">&nbsp;</TD> 
<TD VALIGN="top">Title:</TD> 
<TD VALIGN="bottom">&nbsp;</TD> 
<TD VALIGN="top">President &amp; CEO</TD></TR>
</TABLE> 
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P> 
 
</BODY></HTML>
</TEXT>
</DOCUMENT>
